NCT05989698Recruiting
Validation of the C-mo System - Cough Monitoring
Source: ClinicalTrials.gov · Last updated 8 Apr 2026
Brief summary (registry, in English)
The goal of this clinical study is to validate C-mo System's ability to automatically detect and characterise cough, in patients over 2 years old with cough as a key or refractory symptom. The main questions it aims to answer are: 1. Can C-mo System detect cough events? (automatic cough detection) 2. Can C-mo System characterise cough events? (calculation of cough intensity, identification of cough type and presence of wheeze in detected coughs) Participants will be asked to: * Wear the C-mo Wearable device for 24 hours (1 day); * Complete a diary with relevant activities throughout the monitoring period; * Fill-out questionnaires related to coughing frequency and intensity, usability of the device, and impact of cough on quality of life.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 12 May 2023
- Start date
- 11 Dec 2023
- Primary completion date
- Jun 2026
- Lead sponsor
- Cough Monitoring Medical Solutions
- Diseases
- Idiopathic pulmonary fibrosis, Asthma, COPD
- NCT number
- NCT05989698
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 11 Dec 2023 to the primary completion date, Jun 2026
- 8 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of musculoskeletal (e.g., severe scoliosis), neurological (e.g., post stroke), cardiac (e.g., unstable angina), cognitive (e.g., dementia) changes, or other significant conditions that hinder the participants from collaborating in the collection of data.
Other
- Damaged/weakened skin at the C-mo wearable device's placement area (epigastric region).
- Absence of Informed Consent and/or Assent, as applicable.
Who the study is looking for
- Patients aged 2 years or older;
- Patients with symptoms/complaints of cough;
- Signed Informed Consent (age ≥ 18 years), signed Informed Consent from the parents/legal representative and the patient (16 and 17 years), or signed Informed Assent and Consent (5 years ≤ age ≤ 15 years).
Age in the registry: 2 years to - · Sex: All · Does not accept healthy volunteers
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HPAV - Trofa Saúde Hospital de Alfena Coordinator of this site? Confirm its status | Alfena | Portugal | Recruiting |
| HFF - Hospital Professor Doutor Fernando Fonseca Coordinator of this site? Confirm its status | Amadora | Portugal | Recruiting |
| Lab3R - Laboratório de Investigação e Reabilitação Respiratória da Escola Superior de Saúde da Universidade de Aveiro Coordinator of this site? Confirm its status | Aveiro | Portugal | Completed |
| CHUC - Centro Hospitalar e Universitário de Coimbra Coordinator of this site? Confirm its status | Coimbra | Portugal | Recruiting |
| HDE - Hospital Dona Estefânia Coordinator of this site? Confirm its status | Lisbon | Portugal | Recruiting |
| NMS Research - Laboratório de Exploração Funcional | Fisiopatologia Coordinator of this site? Confirm its status | Lisbon | Portugal | Recruiting |
| CHUSJ - Centro Hospitalar Universitário de São João Coordinator of this site? Confirm its status | Porto | Portugal | Recruiting |
| ICUFP - Instituto CUF Porto Coordinator of this site? Confirm its status | Porto | Portugal | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.